Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04980521 · ClinicalTrials.gov registry record · NA

Promoting Radon Testing Via Smartphone App: A Clinical Trial in a High Radon State

A NA study of Lung Cancer, sponsored by University of North Dakota.

Completed
Registry status
NA
Development phase
138
Enrollment target
1
Study location

NCT04980521: Completed NA study of Lung Cancer, sponsored by University of North Dakota.

NCT04980521 is a NA study of Lung Cancer that has completed, run by University of North Dakota. The registered enrollment target is 138 participants, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04980521, a NA study of Lung Cancer, has completed, sponsored by University of North Dakota.

COMPLETED
Registry status
NA
Development phase
138 participants
Enrollment target
1
Study location

Study Summary

This research will compare (1) the effectiveness of a mobile radon-education app (vs. traditional brochures) and (2) that of the radon app with in-app reminders (vs. the radon app without in-app reminders and the no app use with postal reminders) to increase radon awareness and testing among North Dakotans. The prevalence of exceptionally high levels of residential radon in North Dakota (ND), coupled with public's poor understanding of this hazard, is a critical public health problem.

Conditions Studied

Interventions

  • OTHER The radon app
  • OTHER Print brochure

Study Locations (1)

North Dakota

  • University of North Dakota - Grand Forks

Trial Details

FieldValue
Enrollment Target 138 participants
Start Date 2021-10-01
Est. Completion 2023-03-31
Phase NA

Sponsor

University of North Dakota

4 total trials

What the Registry Record Tells You About NCT04980521

The ClinicalTrials.gov registry entry for NCT04980521 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 138 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (85% lower). The listed sponsor is University of North Dakota, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 2 interventions - of which The radon app is the first listed.

NCT04980521 reports 1 study location spanning 1 distinct geographic area - top geographies include North Dakota.

Frequently Asked Questions

What is clinical trial NCT04980521 about?

NCT04980521 is a clinical study titled "Promoting Radon Testing Via Smartphone App: A Clinical Trial in a High Radon State". This research will compare (1) the effectiveness of a mobile radon-education app (vs. traditional brochures) and (2) that of the radon app with in-app reminders (vs. the radon app without in-app reminders and the no app use with postal reminders) to increase radon awareness and testing among North D...

What is the current status of trial NCT04980521?

This trial is currently completed. It is a NA study. The enrollment target is 138 participants. The study started on 2021-10-01. Estimated completion is 2023-03-31.

What conditions does trial NCT04980521 study?

This clinical trial studies the following conditions: Lung Cancer.

What interventions are being tested in trial NCT04980521?

The interventions under investigation include: The radon app (OTHER), Print brochure (OTHER).

Who is sponsoring clinical trial NCT04980521?

This trial is sponsored by University of North Dakota, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04980521 being conducted?

This trial has 1 study location across North Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.